Antimicrobial Agents and Chemotherapy · 2019 · 86 citations · 28 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsBacterial PathogenesisCarbapenem ResistanceResistance GenesCarbapenem AntibioticsCarbapenem Resistance MechanismsCarbapenemase EnzymesEscherichia ColiEscherichia Coli ResistancePorin FunctionPorin Mutation ResistancePorin Proteins
Meropenem-vaborbactam is a new agent with the potential to treat carbapenem-resistant Enterobacteriaceae (CRE) infections. We describe the in vitro activity of meropenem-vaborbactam against representative CRE genotypes and laboratory-engineered Escherichia coli isolates harboring mutant bla KPC genes associated with ceftazidime-avibactam resistance.
28
Ryan K. Shields, M. Hong Nguyen, Liang Chen et al. · Antimicrobial Agents and Chemotherapy · 2017 · 487 citations · Full text
Ryan K. Shields, Liang Chen, Shaoji Cheng et al. · Antimicrobial Agents and Chemotherapy · 2016 · 485 citations · Full text
Ryan K. Shields, Brian A. Potoski, Ghady Haidar et al. · Clinical Infectious Diseases · 2016 · 428 citations · Full text